IBM misses Q2 estimates, trims full-year revenue growth outlook

IBM is set to open ~2% lower after Q2 results missed forecasts and management trimmed outlook. Adjusted EPS was $2.93 vs $2.97 expected, and revenue rose 1% YoY to $17.16B versus $17.58B consensus. The company also lowered its full-year constant-currency revenue growth forecast.

Analysis

This reads less like a one-off miss and more like a credibility hit to IBM’s “stable compounder” premium. When a mature tech name lowers constant-currency growth after already missing both revenue and EPS, the market usually starts to discount not just the current quarter but the next two reporting cycles, because the burden shifts from execution to proof. That tends to compress the multiple first, then force estimate cuts later.

Second-order, the losers are enterprise IT spend names with a heavy services component and weaker recurring software mix: if IBM is seeing softer demand, that usually means customers are stretching decision cycles across infrastructure modernization, app migration, and discretionary consulting. The relative winners are higher-quality software and platform names with clearer budget priority—MSFT and ORCL can absorb share when CIOs consolidate vendors—while pure services peers like ACN/CTSH can get pressured if the slowdown is broad rather than IBM-specific.

The key catalyst is whether this is margin-managed revenue weakness or a genuine demand inflection. Over the next 4-8 weeks, watch for analyst downgrades to FY revenue more than EPS; if management leans on cost actions to preserve earnings, that only delays the debate and can set up a second leg lower when top-line softness persists. The contrarian risk is that the stock is already priced as a low-growth utility, so if bookings/software reaccelerate even modestly, the bear case fades quickly.

For the next 1-3 months, a relative-value short IBM vs long MSFT or ORCL is cleaner than an outright short, since the issue is growth visibility rather than solvency. If you want convexity, use a bearish put spread into any post-earnings bounce rather than chasing the open; the downside thesis is strongest if the next update confirms that constant-currency growth remains subtrend and guidance is still being ratcheted down.

Key Decisions for Investors

• Short IBM vs long MSFT or ORCL for 1-3 months: express a quality-growth rotation trade if IBM’s guidance cut triggers multiple compression while higher-quality software names hold estimates.
• Avoid adding to an outright IBM short immediately after the gap down; wait for any 2-5 day relief rally and then fade it if analyst revisions broaden beyond the current quarter.
• Use a 6-10 week IBM put spread only if implied vol remains below the likely estimate-cut risk; target a move into the next earnings revision cycle rather than a same-day reaction.
• Set a falsifier on IBM’s next update: if constant-currency revenue guidance stabilizes or bookings accelerate, cover the short thesis quickly because the market may already be pricing in most of the deceleration.
• Monitor ACN/CTSH and enterprise software proxies as spillover trades; if IBM weakness is sector-wide, rotate out of services exposure and toward MSFT/ORCL-type recurring revenue exposure.